Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection: a trigger for asthma?

J Asthma. 2023 Jun;60(6):1221-1226. doi: 10.1080/02770903.2022.2139719. Epub 2022 Nov 14.

Abstract

Objective: This study aims to investigate the presence of underlying chronic airway disease in individuals with chronic cough and dyspnea lasting longer than eight weeks and who had previously Coronavirus disease 2019 (COVID-19) and had no known lung disease.Methods: A total of 151 patients admitted to the respiratory diseases outpatient room with the complaint of cough and/or dyspnea that persisted for at least eight weeks following COVID-19 infection were accrued to the study. Demographic characteristics, smoking history, the severity of lung involvement on chest computed tomography in the acute phase of Covid-19 infection, and bronchodilator reversibility test results were recorded. Smoking history and forced expiratory volume in the first second (FEV1) were compared.Results: FEV1 increase ≥ 200 ml was observed in 40 (26.5%) patients. In 24 (15.9%) patients, an increase in FEV1 was found to be 200 ml and above, and the percentage of FEV1 was 12% or more. While 14 (9.3%) patients were diagnosed with asthma, 13 (8.6%) patients were diagnosed with nonreversible airflow obstruction (NRAO), and 1 (0.7%) patient was diagnosed with chronic obstructive pulmonary disease (COPD).Conclusions: COVID-19 infection may play a vital role in initiating asthma pathogenesis. It should be kept in mind that viral infection-related asthma may be the underlying cause of prolonged cough and dyspnea after COVID-19 infection.

Keywords: Post-COVID-19; airway reversibility; bronchial hyperresponsiveness; post-COVID cough; viral infection related-asthma.

MeSH terms

  • Asthma* / complications
  • Asthma* / diagnosis
  • Asthma* / drug therapy
  • Bronchodilator Agents / adverse effects
  • COVID-19* / complications
  • Cough / etiology
  • Dyspnea / etiology
  • Forced Expiratory Volume
  • Humans
  • Pulmonary Disease, Chronic Obstructive* / diagnosis

Substances

  • Bronchodilator Agents